About: Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2002

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2002 (uk) im März 2002 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2002 (ast) scientific article published on 01 March 2002 (en)
publication date	wds:Q77690377-D05C65BD-07E8-436B-BAE4-EDC45D95CD7E
publication date	2002-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q77690377-2507CE5A-478A-4DA9-9028-E8A7C5283472
language of work or name	English
cites work	wds:Q77690377-0D8CA6E3-6FC5-4FD2-A40A-5D4AB52E2E05 wds:Q77690377-339C7F22-8F7D-4D5A-8B17-B6F498EB63D1 wds:Q77690377-38E486FA-94F9-46AB-8D9E-FEEDE149FB24 wds:Q77690377-4EFC4043-57FA-49EF-ABB6-BDC87480D3FB wds:Q77690377-56ECA74D-0502-4748-B7BC-B563DFE642F1 wds:Q77690377-5806490A-2248-4A64-8BBD-5C337E8D5164 wds:Q77690377-836CEBE6-351F-4677-8B6E-17D24100BFD0 wds:Q77690377-9B6F1486-BA6F-4E10-96D4-004B9EFB7781 wds:Q77690377-A84C4BC2-9A39-485E-A96C-580134105F68 wds:Q77690377-C93F1777-1FF8-496A-9C97-B45CB03FAB46 wds:Q77690377-CE7EBFD5-912C-402A-84F0-6700AEF0DDFD wds:Q77690377-D3FF167D-80A9-41A7-9C5B-24D7C2AEFC07 wds:Q77690377-D4BDF707-B57F-4925-A658-5FDBC2F8B2B6 wds:Q77690377-D7BFCFDC-7272-4CFF-B2E5-0AC36A62B0FF wds:Q77690377-DC492099-BCD1-46BA-9BC1-239961C15498 wds:Q77690377-E522A46A-93E0-40E3-A008-17797AA86C48 wds:Q77690377-E6462C84-87C6-4126-AD6F-79D5C0CF2F09 wds:Q77690377-EEBA18D0-AB90-4F34-BCB1-A3E7E103A93B wds:Q77690377-EFF282B4-CEA7-4486-802D-489DF18DA843 wds:Q77690377-F4846674-E8DD-43A6-9EE5-1487594DAF53 wds:Q77690377-F4D8E2B4-2DE4-4606-83AC-2DFC66EE4528
cites work	Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress Human, rat, and mouse kidney cells express functional erythropoietin receptors The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Morphometry of interstitial fibrosis Hypoxia promotes fibrogenesis in human renal fibroblasts Contribution of tubular injury to loss of remnant kidney function. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients Regulation of collagen synthesis by ascorbic acid: characterization of the role of ascorbate-stimulated lipid peroxidation d-alpha-tocopherol inhibits collagen alpha 1(I) gene expression in cultured human fibroblasts. Modulation of constitutive collagen gene expression by lipid peroxidation Renoprotection: one or many therapies? Interstitial fibrosis in hypercholesterolemic rats: Role of oxidation, matrix synthesis, and proteolytic cascades Erythropoietin impairs endothelium-dependent vasorelaxation through cyclooxygenase-dependent mechanisms in humans Effect of recombinant human erythropoietin on endothelial cell apoptosis Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts Redox regulation of renal DNA synthesis, transforming growth factor-beta1 and collagen gene expression Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway Increased nephron oxygen consumption: potential role in progression of chronic renal disease
author name string	wds:Q77690377-5B4A45B5-6957-4434-8C60-6C491CC0F985 wds:Q77690377-D32C8ACD-A61B-4E24-9FA9-647C9A3A9E87 wds:Q77690377-E0683BBB-EB99-4922-B59F-309D1F9C9B12
author name string	Simon D Roger Jerome Rossert Dierik L Verbeelen
rdfs:label	Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? (en) Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? (nl)
skos:prefLabel	Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? (en) Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? (nl)
name	Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? (en) Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? (nl)
author	wds:Q77690377-E42E234A-D79F-4F30-9141-FF7E0A1520B5
author	William M. McClellan
title	wds:Q77690377-9DC86E3A-CEFE-4F1F-9113-949B340661DA
title	Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? (en)
page(s)	wds:Q77690377-ED719818-F9E6-40B4-8EA3-0DF80DDC036D
page(s)	359-362
instance of	wds:Q77690377-50c959ac-1f17-425f-9f31-868cb8778445 wds:Q77690377-7378B749-115D-4CF1-9765-8806C01C4615 wds:Q77690377-fc46cc6d-b783-4bf2-b7f3-7438eadfa061
instance of	editorial review article scholarly article
main subject	wds:Q77690377-64DCC6BC-BE80-4524-9C5A-451E20EED8BF
main subject	kidney disease
PubMed ID	wds:Q77690377-7B4D4927-3E91-4133-88C3-01510563079D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11865076
PubMed ID	11865076
published in	wds:Q77690377-8F8ABE11-5476-466D-B5BE-C9F51D24917E
published in	Nephrology Dialysis Transplantation
issue	wds:Q77690377-AD5152EC-4A9F-485C-9ED7-0B227F6CB195
volume	wds:Q77690377-F5CC6228-50E2-4713-9092-633030819FF7
issue	3
volume	17
DOI	wds:Q77690377-D97E1D0A-4303-4DDD-9A29-2EC3358F34C2
DOI	http://dx.doi.org/10.1093/NDT/17.3.359
DOI	10.1093/NDT/17.3.359
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q77690377
is cites work of	The epidemiology and control of anaemia among pre-ESRD patients with chronic kidney disease Recombinant human epoetin beta in the treatment of renal anemia Hemoglobin predicts long-term survival in dialysis patients: A 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin [Therapy and prophylaxis of renal failure] The epidemiological association of altitude with chronic kidney disease: Evidence of protective effect. Can the progression of chronic renal failure be delayed?
is cites work of	wds:Q36310909-E73C049B-F79E-41DA-9FD1-B23D82BAE9BA wds:Q36661294-09D2DC6C-60A2-4720-A127-CD31C454CA77 wds:Q47579873-4E0C4A8E-65C1-45AC-9839-AB63ACBD2855

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software